These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8709248)

  • 1. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.
    Fruehling S; Lee SK; Herrold R; Frech B; Laux G; Kremmer E; Grässer FA; Longnecker R
    J Virol; 1996 Sep; 70(9):6216-26. PubMed ID: 8709248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.
    Fruehling S; Longnecker R
    Virology; 1997 Sep; 235(2):241-51. PubMed ID: 9281504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
    Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
    J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
    Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
    J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
    Miller CL; Lee JH; Kieff E; Longnecker R
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.
    Longnecker R; Miller CL; Tomkinson B; Miao XQ; Kieff E
    J Virol; 1993 Aug; 67(8):5068-74. PubMed ID: 8392630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
    Ikeda M; Ikeda A; Longnecker R
    J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
    Miller CL; Lee JH; Kieff E; Burkhardt AL; Bolen JB; Longnecker R
    Infect Agents Dis; 1994; 3(2-3):128-36. PubMed ID: 7812651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events.
    Beaufils P; Choquet D; Mamoun RZ; Malissen B
    EMBO J; 1993 Dec; 12(13):5105-12. PubMed ID: 8262054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    J Virol; 1994 Jul; 68(7):4369-76. PubMed ID: 8207810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1.
    Mosialos G; Hanissian SH; Jawahar S; Vara L; Kieff E; Chatila TA
    J Virol; 1994 Mar; 68(3):1697-705. PubMed ID: 8107230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
    Swanson-Mungerson M; Bultema R; Longnecker R
    J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
    Ikeda M; Ikeda A; Longan LC; Longnecker R
    Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
    Rovedo M; Longnecker R
    J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES; Tomkinson B; Kieff E
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.
    Merchant M; Swart R; Katzman RB; Ikeda M; Ikeda A; Longnecker R; Dykstra ML; Pierce SK
    Int Rev Immunol; 2001; 20(6):805-35. PubMed ID: 11913951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
    Portis T; Longnecker R
    Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
    Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
    Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.